BioSpace News Archive

An orthopedic surgeon at Hospital for Special Surgery has performed the first augmented reality knee replacement in the United States.

Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO. Sarah rejoins Psychemedics from Decibel Therapeutics, Inc., a biotech start-up researching hearing loss therapeutics, and Takeda Pharmaceutical Company, Ltd.

Positive and negative coronavirus swabs and associated de-identified medical data can accelerate researchers’ work on treatments and vaccines

The U.S. Food and Drug Administration (FDA) has approved Benlysta to treat lupus nephritis (lupus-related kidney disease) in adults. The approval is for both the intravenous and subcutaneous formulations. The decision makes Benlysta the first lupus therapy authorized to treat this potentially life-threatening complication of the disea

CCT Research, a leader in community-based, embedded clinical research, announced the expansion of its clinical trial operations to the Las Vegas metropolitan area.

Partnership to Fight Infectious Disease Convenes National Conversation Moderated by BBC World News America’s Katty Kay;

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative drug development company, today announced that they have signed a letter of intent to collaborate to seek to enhance nasal drug delivery to the brain of Herantis’ CDNF and xCDNF therapies (Parkinson’s disease) using Nanofor

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the initiation of Phase 2 clinical trials of ADX-629, a first-in-class orally administered reactive aldehyde species (RASP) inhibitor, for the treatment of COVID-19, atopic asthma, and psoriasis as part of a systematic strategy to assess activity across different types of immunological diseases.

Qualtrics, the leader in customer experience and creator of the experience management category, today announced that Quest Diagnostics, one of the largest clinical laboratory testing companies in the United States , has selected Qualtrics EmployeeXM™ and CustomerXM™.

BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the Phase III pivotal CardiAMP™ Heart Failure Trial.